Lung donor selection and management

Proceedings of the American Thoracic Society

Volumn 6, Issue 1, 2009, Pages 28-38

  Van Raemdonck, Dirk ^a   Neyrinck, Arne ^a   Verleden, Geert M ^a   Dupont, Lieven ^a   Coosemans, Willy ^a   Decaluwé, Herbert ^a   Decker, Georges ^a   De Leyn, Paul ^a   Nafteux, Philippe ^a   Lerut, Toni ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Donor management; Extended criteria; Lung transplantation; Organ donor

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; DIURETIC AGENT; DOPAMINE; LIOTHYRONINE; METHYLPREDNISOLONE; PLACEBO; SALBUTAMOL; STEROID; THYROXINE; VASOPRESSIN;

AGE; ANAMNESIS; ARTERIAL GAS; ARTIFICIAL VENTILATION; ATELECTASIS; BACTERIAL STRAIN; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BRAIN DEATH; BRONCHOSCOPY; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL PROTOCOL; CLINICAL TRIAL; DONOR SELECTION; DRUG MEGADOSE; GRAFT DYSFUNCTION; GRAFT INFECTION; GRAFT RECIPIENT; HEALTH CARE UTILIZATION; HEMODYNAMIC MONITORING; HORMONE SUBSTITUTION; HUMAN; HYPERACUTE GRAFT REJECTION; LOW DRUG DOSE; LUNG FUNCTION; LUNG INJURY; LUNG TRANSPLANTATION; MEDICAL DECISION MAKING; NONHUMAN; ORGAN DONOR; ORGAN SIZE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; THORAX RADIOGRAPHY;

AGE FACTORS; CADAVER; COMORBIDITY; DONOR SELECTION; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; RISK FACTORS; SEX FACTORS; WAITING LISTS;

EID: 58549084371     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200808-098GO     Document Type: Review

References (139)

1. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. The Registry of The International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007;26:782-795.
2. UNOS scientific registry data (accessed July 10, 2008). Available from: http://www.OPTN.org.
3. Eurotransplant International Foundation. Eurotransplant: donation, waiting lists, and transplants. In: Oosterlee A, Rahmel A, editors. Annual Report 2007 of the Eurotransplant International Foundation. Leiden: Eurotransplant International Foundation; 2007. pp. 24-29.
4. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplantation effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001;20:518-524.
5. Dark JH. Priorities for lung transplantation. Lancet 1998;351:24-27.
6. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, et al. Development of the new lung allocation score in the United States. Am J Transplant 2006;6:1212-1227.
7. Gries CJ, Mulligan MS, Edelman JD, Raghu G, Curtis JR, Goss CH. Lung allocation score for lung transplantation; impact on disease severity and survival. Chest 2007;132:1954-1961.
8. Hsieh AH, Bishop MJ, Kubilis PS, Newell DW, Pierson D. Pneumonia following closed head injury. Am Rev Respir Dis 1992;146:290-294.
9. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 2003;75:1928-1933.
10. Riou B, Guesde R, Jacquens Y, Duranteau R, Viars P. Fiberoptic bronchoscopy in brain-dead organ donors. Am J Respir Crit Care Med 1994;150:558-560.
11. Ware LB, Fang X, Wang Y, Babcock WD, Jones K, Matthay MA. High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation. J Heart Lung Transplant 2005;24:1650-1656.
12. Hornby K, Ross H, Keshavjee S, Rao V, Shemie SD. Non-utilization of hearts and lungs after consent for donation: a Canadian multicentre study. Can J Anaesth 2006;53:831-837.
13. Ware LB, Wang Y, Fang X, Warnock M, Sakuma T, Hall TS, Matthay M. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002;360:619-620.
14. de Perrot M, Snell GI, Babcock WD, Meyers BF, Patterson GA, Hodges TN, Keshavjee S. Strategies to optimize the use of currently available lung donors. J Heart Lung Transplant 2004;23:1127-1134.
15. Van Raemdonck D, Coosemans W, Klepetko W, Dark JH, Steen S, Rega F; Co-authors of Working Group 2. Alternatives to lung donor shortage. Eur Respir Mon 2004;29:89-112.
16. Barr ML, Schenkel FA, Bowdish ME, Starnes VA. Living donor lobar lung transplantation: current status and future directions. Transplant Proc 2005;37:3983-3986.
17. Date H, Yamane M, Toyooka S, Okazaki M, Aoe M, Sano Y. Current status and potential of living-donor lobar lung transplantation. Front Biosci 2008;13:1433-1439.
18. Couetil JP, Tolan MJ, Loulmet DF, Guinvarch A, Chevalier PG, Achkar A, Birmbaum P, Carpentier AF. Pulmonary bipartitioning and lobar transplantation: a new approach to donor organ shortage. J Thorac Cardiovasc Surg 1997;113:529-537.
19. Aigner C, Mazhar S, Jaksch P, Seebacher G, Taghavi S, Marta G, Wisser W, Klepetko W. Lobar transplantation, split lung transplantation, and peripheral segmental resection - reliable procedures for downsizing donor lungs. Eur J Cardiothorac Surg 2004;25:179-183.
20. Couetil JP, Argyriadis PG, Tolan MJ, Achkar A, Carpentier AF. Contralateral lung transplantation: a left lung implanted in the right thorax. Ann Thorac Surg 2001;72:933-935.
21. Mason DP, Murthy SC, Gonzalez-Stawinski GV, Budev MM, Mehta AC, McNeill AM, Pettersson GB. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant 2008;27:561-563.
22. Snell GI, Levvey BJ, Oto T, McEgan R, Pilcher D, Davies A, Marasco S, Rosenfeldt F. Intermediate lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant 2008;8:1282-1289.
23. Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001;357:825-829.
24. de Antonio DG, Marcos R, Laporta R, Mora G, García-Gallo C, Gámez P, Córdoba M, Moradiellos J, Ussetti P, Carreño MC, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 2007;26:529-534.
25. Dark JH. Lung transplantation from the non-heart beating donor. Transplantation 2008;86:200-201.
26. Steen S, Ingemansson R, Eriksson L, Pierre L, Algotsson L, Wierup P, Liao Q, Eyjolfsson A, Gustafsson R, Sjöberg T. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007;83:2191-2195.
27. Yeung JC, Cypel M, Waddell TK, Van Raemdonck D, Keshavjee S. Update on donor assessment, resuscitation and acceptance criteria including novel techniques - non heart beating donor lung retrieval and ex vivo donor lung perfusion. Thorac Surg Clin (In press)
28. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion induced lung injury. Am J Respir Crit Care Med 2003;167:490-511.
29. Christie JD, Van Raemdonck D, de Perrot M, Barr M, Keshavjee S, Arcasoy S, Orens J; Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on primary lung graft dysfunction Part I: introduction and methods. J Heart Lung Transplant 2005;24:1451-1453.
30. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on primary lung graft dysfunction Part II: Definition. J Heart Lung Transplant 2005;24:1454-1459.
31. Sommers KE, Griffith BP, Hardesty RL, Keenan RJ. Early lung allograft function in twin recipients from the same donor: risk factor analysis. Ann Thorac Surg 1996;62:784-790.
32. de Perrot M, Bonser RS, Dark J, Kelly RF, McGiffin D, Menza R, Pajaro O, Schueler S, Verleden GM. Report of the ISHLT Working Group on primary lung graft dysfunction Part III: donor-related risk factors and markers. J Heart Lung Transplant 2005;24:1460-1467.
33. Harjula A, Baldwin JC, Starnes VA, Stinson EB, Oyer PE, Jamieson SW, Shumway NE. Proper donor selection for heart-lung transplantation: the Stanford experience. J Thorac Cardiovasc Surg 1987;94:874-880.
34. Calhoon JK, Trinkle JK. Lung transplantation: donor selection and management. Chest Surg Clin N Am 1993;3:19-28.
35. Cooper JD. The lung donor: special considerations. Transplant Proc 1988;20:17-18.
36. Zenati M, Dowling RD, Armitage JM, Kormos RL, Dummer JS, Hardesty RL, Griffith BP. Organ procurement for pulmonary transplantation. Ann Thorac Surg 1989;48:882-886.
37. Griffith BP, Zenati M. The pulmonary donor. Clin Chest Med 1990;11:217-226.
38. Winton TL, Miller JD, Scavuzzo M, Maurer JR, Patterson GA; the Toronto Lung Transplant Group. Donor selection for pulmonary transplantation. Transplant Proc 1991;23:2472-2474.
39. Winton TL. Lung transplantation: donor selection. Semin Thorac Cardiovasc Surg 1992;4:79-82.
40. Egan T. Selection and management of the lung donor. In: Patterson GA, Couraud L, editors. Current topics in general thoracic surgery. Amsterdam: Elsevier; 1995. pp. 103-115.
41. Frost AE. Donor criteria and evaluation. Clin Chest Med 1997;18:231-237.
42. Aigner C, Seebacher G, Klepetko W. Lung transplantation: donor selection. Chest Surg Clin N Am 2003;13:429-442.
43. Orens JB, Boehler A, de Perrot M, Estenne M, Glanville AR, Keshavjee S, Kotloff R, Morton J, Studer SM, Van Raemdonck D, et al.; Pulmonary Council, International Society for Heart and Lung Transplantation. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003;22:1183-1200.
44. Botha P, Fisher AJ, Dark JH. Marginal lung donors: a diminishing margin of safety? Transplantation 2006;82:1273-1279.
45. Novick RJ, Bennett LE, Meyer DM, Hosenpud JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999;18:425-431.
46. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest 2000;118:1255-1262.
47. Fischer S, Gohrbandt B, Struckmeier P, Niedermeyer J, Simon A, Hagl C, Kallenbach K, Haverich A, Strüber M. Lung transplantation with lungs from donors fifty years of age and older. J Thorac Cardiovasc Surg 2005;129:919-925.
48. Dahlman S, Jeppsson A, Schersten H, Nilsson F. Expanding the donor pool: lung transplantation with donors 55 years and older. Transplant Proc 2006;38:2691-2693.
49. de Perrot M, Waddell TK, Shargall Y, Pierre AF, Fadel E, Uy K, Chaparro C, Hutcheon M, Singer LG, Keshavjee S. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007;133:525-531.
50. ISHLT Registry slides (accessed August 18, 2008). Available from: http://www.ishlt.org/downloadables/lung-adult.ppt.
51. Snell GI, Rabinov M, Griffiths A, Williams T, Ugoni A, Salamonsson R, Esmore D. Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation. J Heart Lung Transplant 1996;15:169-174.
52. Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF, Stern M, Loirat P, Lesèche G, Bertocchi M, et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 2005;171:786-791.
53. Gammie JS, Drukus DR, Pham SM. Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg 1999;68:2015-2020.
54. Yu NC, Haug MT III, Khan SU, Goormastic M, Hague LK, Mehta AC, Maurer JR. Does the donor-recipient ABO blood group campatibility status predict subsequent lung transplantation outcome? J Heart Lung Transplant 1999;18:764-768.
55. Novick RJ, Schafers HJ, Stitt L, Andréassian B, Duchatelle JP, Klepetko W, Hardesty RL, Frost A, Patterson GA. Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients. J Thorac Cardiovasc Surg 1995;110:1402-1413.
56. Sato M, Gutierrez C, Kaneda H, Liu M, Waddell TK, Keshavjee S. The effect of gender combinations on outcome in human lung transplantation: the International Society of Heart and Lung Transplantation Registry experience. J Heart Lung Transplant 2006;25:634-637.
57. Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF, Stern M, Loirat P, Bertocchi M, Mornex JF, et al. Influence of donor characteristics on outcome after lung transplantation: a multicenter study. J Heart Lung Transplant 2005;24:1347-1353.
58. Tamm M, Higenbottam T, Dennis CM, Sharples LD, Wallwork J. Donor and recipient predicted lung volume and lung size after heart-lung transplantation. Am J Respir Crit Care Med 1994;150:403-407.
59. Wisser W, Klepetko W, Wekerle T, Laufer G, Stift A, Hiesmayr M, Schlick W. Tailoring of the lung to overcome size disparities in lung transplantation. J Heart Lung Transplant 1996;15:239-242.
60. Ciccone AM, Stewart KC, Meyers BF, Guthrie TJ, Battafarano RJ, Trulock EP, Cooper JD, Patterson GA. Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg 2002;123:429-434.
61. Waller DA, Thompson AM, Wrightson WN, Gould FK, Corris PA, Hilton CJ, Forty J, Dark JH. Does the mode of donor death influence the early outcome of lung transplantation? A review of lung transplantation from donors involved in major trauma. J Heart Lung Transplant 1995;14:318-321.
62. Ruiz I, Gavaldà J, Monforte V, Len O, Román A, Bravo C, Ferrer A, Tenorio L, Román F, Maestre J, et al. Donor-to-host transmission of bacterial and fungal infections in lung transplantation. Am J Transplant 2006;6:178-182.
63. Ciulli F, Tamm M, Dennis CM, Biocina B, Mullins P, Wells FC, Large SR, Wallwork J. Donor-transmitted bacterial infection in heart-lung transplantation. Transplant Proc 1993;25:1155-1156.
64. Bolton JS, Padia SA, Borja MC, Becker P, Orens JB, Wiener C, Yang SC, Conte JV. The predictive value and inter-observer variability of donor chest radiograph interpretation in lung transplantation. Eur J Cardiothorac Surg 2003;23:484-487.
65. Powner DJ, Biebuyck JC. Introduction to the interpretation of chest radiographs during donor care. Prog Transplant 2005;15:240-248.
66. Puskas JD, Winton TL, Miller DJ, Scavuzzo M, Patterson GA. Unilateral donor lung dysfunction does not preclude successful contralateral single-lung transplantation. J Thorac Cardiovasc Surg 1992;103:1015-1017.
67. McCowin MJ, Hall TS, Babcock WD, Solinger LL, Hall KW, Jablons DM. Changes in radiographic abnormalities in organ donors: associations with lung transplantation. J Heart Lung Transplant 2005;24:323-330.
68. Weill D, Dey GC, Young KR, Zorn GL, Early LJ, Hicks RA, Kirklin J, McGiffin DC. A positive donor gram stain does not predict the development of pneumonia, oxygenation or duration of mechanical ventilation following lung transplantation [abstract]. J Heart Lung Transplant 2001;20:255.
69. Zenati M, Dowling RD, Dummer JS, Paradis IL, Arena VC, Armitage JM, Kormos RL, Hardesty RL, Griffith BP. Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Lung Transplant 1990;9:502-509.
70. Bonde PN, Patel ND, Borja MC, Allan SH, Barreiro CJ, Williams JA, Thakur NA, Orens JB, Conte JV. Impact of donor lung organisms on post-lung transplant pneumonia. J Heart Lung Transplant 2006;25:99-105.
71. Avlonitis VS, Krause A, Luzzi L, Powell H, Phillips JA, Corris PA, Gould FK, Dark JH. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003;24:601-607.
72. 2. J Heart Lung Transplant 2005;24:1347-1353.
73. Lardinois D, Banysch M, Korom S, Hillinger S, Rousson V, Boehler A, Speich R, Weder W. Extended donor lungs: eleven years experience in a consecutives series. Eur J Cardiothorac Surg 2005;27:762-767.
74. Aziz TM, El-Gamel AL, Saad RA, Migliore M, Campbell CS, Yonan NA. Application of pulmonary vein gas analysis: a novel approach which may increase the pool of potential lung transplant donors. Ann Thorac Surg 2002;73:1599-1604.
75. Botha P, Trivedi D, Searl CP, Corris PA, Schueler SV, Dark JH. Differential pulmonary vein gases predict primary graft dysfunction. Ann Thorac Surg 2006;82:1998-2002.
76. McGiffin DC, Zorn GL Jr, Young R Jr, Kirklin JK, Leon KJ, Wille KM, Brown RN, Naftel DC, Hart K, Lalisan D. The intensive care unit oxygen challenge should not be used for donor lung function decision-making. J Heart Lung Transplant 2005;24:1902-1905.
77. De Soyza AG, Dark JH, Parums DV, Curtis A, Corris PA. Donor-acquired small cell lung cancer following pulmonary transplantation. Chest 2001;120:1030-1031.
78. de Perrot M, Wigle DA, Pierre AF, Tsao MS, Waddell TK, Todd TR, Keshavjee SH. Bronchogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003;75:367-371.
79. Bhorade S, Vigneswaran W, McCabe M, Garrity E. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000;19:1200-1204.
80. Oto T, Griffiths AP, Levvey B, Pilcher DV, Whitford H, Kotsimbos TC, Rabinov M, Esmore DS, Williams TJ, Snell GI. A donor history of smoking affects early but not late outcome in lung transplantation. Transplantation 2004;78:599-606.
81. Penn I. Transmission of cancer from organ donors. Ann Transplant 1997;2:7-12.
82. Kauffmann HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000;70:1747-1751.
83. Detry O, Honoré P, Hans MF, Delbouille MH, Jacquet N, Meurisse M. Organ donors with primary central nervous system tumor. Transplantation 2000;70:244-248.
84. Weill D. Donor criteria in lung transplantation: an issue revisited. Chest 2002;121:2029-2031.
85. Fisher AJ, Dark JH, Corris PA. Improving donor lung evaluation: a new approach to increase organ supply for lung transplantation. Thorax 1998;53:818-820.
86. Fisher AJ, Donnelly SC, Pritchard G, Dark JH, Corris PA. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax 2004;59:434-437.
87. Oto T, Lewwey B, Whitford H, Griffiths A, Kotsimbos T, Williams TJ, Snell GI. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg 2007;83:257-264.
88. Cypel M, Yildirim E, Boasquevisque C, Anraku M, Sales VT, Rodrigues DE, Payne C, Pierre A, de Perrot M, Keshavjee S, et al. Donor scoring does not predict early outcome [abstract]. J Heart Lung Transplant 2008;27:S251.
89. Fisher AJ, Donnelly SC, Hirani N, Haslett C, Strieter RM, Dark JH, Corris PA. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001;163:259-265.
90. Kaneda H, Waddell TK, de Perrot M, Bai XH, Gutierrez C, Arenovich T, Chaparro C, Liu M, Keshavjee S. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predict survival after lung transplantation in humans. Am J Transplant 2006;6:544-551.
91. Stewart S, Ciulli F, Wells FC, Wallwork J. Pathology of unused donor lungs. Transplant Proc 1993;25:1167-1168.
92. Husain AN, Hinkamp TJ. Donor lung pathology: correlation with outcome of transplanted contralateral lung. J Heart Lung Transplant 1993;12:932-939.
93. Egan TM, Boychuk JE, Rosato K, Cooper JD. Whence the lungs? A study to assess suitability of donor lungs for transplantation. Transplantation 1992;53:420-422.
94. Egan TM. The other lung revisited-again. J Heart Lung Transplant 1993;12:940.
95. Meers C, Van Raemdonck D, Verleden GM, Coosemans W, Decaluwe H, De Leyn P, Nafteux P, Lerut T. Whence the lungs? A review of current lung donor profile and acceptance rate [abstract]. Interactive Cardiovascular and Thoracic Surgery 2008;7:S161.
96. Neyrinck A, Rega F, Jannis N, Van Gelder F, Vandezande E, Verleden GM, Coosemans W, De Leyn P, Nafteux Ph, Lerut T, et al. Ex vivo reperfusion of human lungs declined for transplantation: a novel approach to alleviate donor organ shortage? [abstract] J Heart Lung Transplant 2004;23:S173.
97. Wierup P, Haraldsson A, Nilsson F, Pierre L, Scherstén H, Silverborn M, Sjöberg T, Westfeldt U, Steen S. Ex vivo evaluation of non-acceptable donor lungs. Ann Thorac Surg 2006;81:460-466.
98. Egan TM, Haithcock JA, Nicotra WA, Koukoulis G, Inokawa H, Sevala M, Molina PL, Funkhouser WK, Mattice BJ. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg 2006;81:1205-1213.
99. Kron I, Tribble C, Kern J, Daniel TM, Rose CE, Truwit JD, Blackbourne LH, Bergin JD. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 1993;217:518-524.
100. Shumway S, Hertz M, Petty M, Bolman R. Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg 1994;57:92-95.
101. Sundaresan S, Semenkovich J, Ochoa L, Richardson G, Trulock EP, Cooper JD, Patterson GA. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995;109:1075-1080.
102. Gabbay E, Williams TJ, Griffiths AP, Macfarlane LM, Kotsimbos TC, Esmore DS, Snell GI. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999;160:265-271.
103. Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002;124:250-258.
104. Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002;123:421-427.
105. Aigner C, Winkler G, Jaksch P, Seebacher G, Lang G, Taghavi S, Wisser W, Klepetko W. Extended donor criteria for lung transplantation: a clinical reality. Eur J Cardiothorac Surg 2005;27:757-761.
106. Botha P, Trivedi D, Weir CJ, Searl CP, Corris PA, Dark JH, Schueler SV. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006;131:1154-1160.
107. Bittner HB, Kendall SW, Chen EP, Craig D, Van Trigt P. The effects of brain death on cardiopulmonary hemodynamics and pulmonary blood flow characteristics. Chest 1995;108:1358-1363.
108. Novitzky D, Wicomb WN, Rose AG, Cooper DK, Reichart B. Pathophysiology of pulmonary edema following experimental brain death in the chacma baboon. Ann Thorac Surg 1987;43:288-294.
109. van der Zee H, Malik AB, Lee BC, Hakim TS. Lung fluid and protein exchange during intracranial hypertension and role of sympathetic mechanisms. J Appl Physiol 1980;48:273-280.
110. Fisher AJ, Donnelly SC, Hirani N, Burdick MD, Strieter RM, Dark JH, Corris PA. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 1999;353:1412-1413.
111. Avlonitis VS, Wigfield CH, Golledge HD, Kirby JA, Dark JH. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant 2007;7:83-90.
112. Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005;5:684-693.
113. Neyrinck AP, Van De Wauwer C, Geudens N, Rega FR, Verleden GM, Wouters P, Lerut TE, Van Raemdonck DE. Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur J Cardiothorac Surg 2006;30:628-636.
114. McElhinney DB, Khan JH, Babcock WD, Hall TS. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transpl 2001;15:68-71.
115. Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002;2:701-711.
116. Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organs. Transplantation 1993;56:1418-1422.
117. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995;59:58-62.
118. Rosendale JD, Chabalewski FL, McBride MA, Garrity ER, Rosengard BR, Delmonico FL, Kauffman HM. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002;2:761-768.
119. Mukadam ME, Harrington DK, Wilson IC, Mascaro JG, Rooney SJ, Thompson RD, Nightingale P, Bonser R. Does donor catecholamine administration affect early lung function after transplantation? J Thorac Cardiovasc Surg 2005;130:926-927.
120. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003;75:482-487.
121. Rostron AJ, Avlonitis VS, Cork DMW, Grenade DS, Kirby JA, Dark JH. Hemodynamic resuscitation with arginine vasopressine reduces lung injury following brain death in the transplant donor. Transplantation 2008;85:597-606.
122. Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation 2006;82:1396-1401.
123. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17:423-429.
124. Venkateswaran RV, Patchell VB, Wilson IC, Mascaro JG, Thompson RD, Quinn DW, Stockley RA, Coote JH, Bonser RS. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008;85:278-286.
125. Salim A, Martin M, Brown C, Inaba K, Roth B, Hadjizacharia P, Mascarenhas A, Rhee P, Demetriades D. Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation. Clin Transplant 2007;21:405-409.
126. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 2003;75:1336-1341.
127. Folkesson HG, Norlin A, Wang Y, Abedinpour P, Matthay MA. Dexamethasone and thyroid hormone pretreatment upregulate alveolar epithelial fluid clearance in adult rats. J Appl Physiol 2000;88:416-424.
128. Ware LB, Fang X, Wang Y, Sakuma T, Hall TS, Matthay MA. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol 2002;93:1869-1874.
129. Neyrinck A, Rega F, Fransen L, De Winter H, Jannis N, Wouters P, Verleden GM, Lerut T, Van Raemdonck DEM. β-adrenergic stimulation of alveolar liquid clearance: a novel strategy to resolve pulmonary edema after lung transplantation? [abstract] Eur J Anaesthesiol 2004;21:A664.
130. Neyrinck AP, Rega FR, Van De Wauwer C, Geudens N, Verleden GM, Wouters P, Lerut TE, Van Raemdonck DEM. Terbutaline attenuates reperfusion injury in the donor lung from HBD and NHBD [abstract]. J Heart Lung Transplant 2007;26:S170-S171.
131. Chen F, Nakamura T, Fujinaga T, Zhang J, Hamakawa H, Omasa M, Sakai H, Hanaoka N, Bando T, Wada H, et al. Protective effect of a nebulized beta2-adrenoreceptor agonist in warm-ischemic-reperfused rat lungs. Ann Thorac Surg 2006;82:465-471.
132. Mascia L, Bosma K, Pasero D, Galli T, Cortese G, Donadio P, Bosco R. Ventilatory and hemodynamic management of potential donors: an observational study. Crit Care Med 2006;34:321-327.
133. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
134. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327-336.
135. Cummings J, Houck J, Lichtenfield D. Positive effects of agressive resuscitative efforts on cadaver lung procurement. J Transpl Coord 1995;5:103-106.
136. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995;14:734-742.
137. Lloyd-Jones H, Wheeldon DR, Smith JA, Potter CD, Wallwork J, Large SR. An approach to retrieval of thoracic organs for transplantation. AORN J 1996;63:416-423.
138. Parry A, Higgins R, Wheeldon D, Bethune D, Wallwork J. The contribution of donor management and modified cold blood lung perfusate to post-transplant lung function. J Heart Lung Transplant 1999;18:121-126.
139. Angel LF, Levine DJ, Restrepo MI, Johnson S, Sako E, Carpenter A, Calhoon J, Cornell JE, Adams SG, Chisholm GB, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 2006;174:710-716.